LKFT
Galapagos N.V. Sponsored ADR
NASDAQ · Healthcare · Biotechnology · US
$29.79
−0.37%Margins
Gross margin
94.9%
EBITDA margin
54.2%
EBIT margin
61.6%
Net margin
60.2%
FCF margin
-19.9%
18.3%
Return on equity
17.8%
Return on assets
18.7%
Return on invested capital
0.29x
Asset turnover
-$216.3M
Cash from operations
$38
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026